Evaluation of medical sterile maggot therapy on intractable gangrene and ulcer.

Evaluation of medical sterile maggot therapy on intractable gangrene and ulcer. - MDT (Maggot Debridement Therapy) Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011439

Enrollment

Registered

2013-08-10

Start date

2013-08-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intractable gangrene and ulcer.

Interventions

Medical sterile maggot (Biotherapy Medical Co., Ltd)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who will be able to obtain written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients whom internal organs and/or large blood vessels has exposed from the wound. 2. Patients who have the osteomyelitis. 3. Patients who have risk of severe liver failure and/or brain dysfunction. 4. Cannot be obtained the consent of the patient and family. 5. Patients who were judged to be inappropriate by the investigator.

Design outcomes

Primary

Measure	Time frame
The size of necrosis.	—

Countries

Japan

Contacts

Public ContactToru Miyanaga

Kanazawa Medical University Plastic and Reconstructive Surgery

miyanaga@kanazawa-med.ac.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026